Belén Rebeca Cortez Zambrano

Dr. Belén Rebeca Cortez Zambrano

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Carlos Barba-OstriaCarlos Barba-Ostria
Carlos Barba-Ostria
Melanie Aylin Cedeño ZambranoMelanie Aylin Cedeño Zambrano
Melanie Aylin Cedeño Zambrano
Juan A. Puente-PinedaJuan A. Puente-Pineda
Juan A. Puente-Pineda
BZBelén Rebeca Cortez Zambrano
Belén Rebeca Cortez Zambrano
JGJessica Maritza Guamán-Bautista
Jessica Maritza Guamán-Bautista
Linda GuamanLinda Guaman
Linda Guaman
Antimicrobial resistance (AMR) and biofilm-associated infections represent major therapeutic challenges because they reduce antimicrobial susceptibility, promote persistence, and limit the effectiveness of conventional treatments. Phytochemicals offer a complementary strategy due to their multitarget antimicrobial and antibiofilm activities, including membrane disruption, oxidative stress induction, quorum-sensing interference, efflux-pump inhibition, and disruption of extracellular polymeric substances. However, their clinical application is frequently restricted by poor aqueous solubility, chemical instability, rapid degradation, limited bioavailability, and insufficient accumulation at infection sites. Encapsulation provides a means to overcome these limitations through physicochemical protection, controlled release, and improved local delivery. This review examines the main delivery platforms used to formulate antibacterial phytochemicals against multidrug-resistant and biofilm-associated bacterial pathogens, with emphasis on how carrier materials and formulation parameters influence antimicrobial and antibiofilm activity. Translational applications in antimicrobial coatings, medical devices, wound and burn infections, and combination therapies are critically discussed. Current limitations related to manufacturing scalability, reproducibility, safety, regulatory classification, methodological heterogeneity, and the limited progression from in vitro studies to clinically relevant models are also discussed. Overall, encapsulation can expand the therapeutic potential of phytochemicals, but future progress will depend on demonstrating reproducible advantages over free compounds through standardized formulation, appropriate controls, relevant preclinical models, and early integration of safety and regulatory requirements.

13 August 2026 in Journal of the World Aquaculture Society
Verified
Journal Article
Open access
PDF file
AGArleth Gualle
Arleth Gualle
LOLourdes M. Orejuela-Escobar
Lourdes M. Orejuela-Escobar
DCDiana Raquel Celi
Diana Raquel Celi
KNKarla Nolivos‐Rodriguez
Karla Nolivos‐Rodriguez
DADaniel Aguilera‐Pesantes
Daniel Aguilera‐Pesantes
AMAntónio Machado
António Machado
Opportunistic pathogens represent a significant threat to shrimp aquaculture, as they can reduce productivity and cause substantial economic losses. Plant‐derived compounds have been investigated as potential alternatives for controlling bacterial infections associated with shrimp farming. In this study, a bioprospecting screening of 31 plant species collected from the localities of Taura and Sangolquí (Ecuador) was conducted to evaluate their antioxidant and antibacterial activities against bacterial species associated with aquaculture systems. Among the evaluated extracts, Eucalyptus globulus Labill. and Psidium guajava L. leaves exhibited notable bioactive potential and were selected for further analysis. The antioxidant activity of the extracts was assessed using ferric reducing antioxidant power (FRAP) and 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) assays. Antibacterial activity was evaluated using disk diffusion and microdilution methods. In addition, fractions from the most active extracts were analyzed using HPLC‐DAD‐MS/MS to explore their chemical composition and potential association with antibiofilm activity. The results showed that Eucalyptus globulus and Psidium guajava leaf extracts exhibited minimum inhibitory concentration (MIC) values ranging from 250 to 20,000 μg/mL against the tested Vibrio species and P. aeruginosa strains, with Eucalyptus extracts generally showing lower MIC values and a more consistent inhibitory profile across extraction solvents. Antioxidant activity was also observed in methanolic extracts. Fraction F5 of the Eucalyptus leaf extract reduced biofilm biomass by up to 76.09% and viable cells by 70.15%. For Psidium guajava leaves, fractions F1 (61.98%–71.69%), F4 (55.14%–70.02%), and F6 (38.84%–65.88%) showed the highest antibiofilm activity, particularly against mature biofilms associated with Vibrio spp., while limited activity was observed against Pseudomonas aeruginosa . HPLC‐DAD‐MS/MS analysis tentatively identified several metabolites belonging to the flavonoid group in the most active fractions. Overall, the results suggest that extracts from Eucalyptus globulus and Psidium guajava leaves possess antioxidant and antibacterial activities that may represent promising candidates for further investigation as plant‐derived antimicrobial agents for aquaculture systems. However, additional studies, including in vivo validation, toxicity assessment, and formulation development, are required before practical application.